TAKEDA
LIVE

Serial Number

98377540

Owner

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Attorney

Karl M. Zielaznicki, Esq.

First Use Date

Jan 1, 2020

Filing Date

Jan 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TAKEDA Trademark

Serial Number: 98377540

TAKEDA is a trademark filed by TAKEDA PHARMACEUTICAL COMPANY LIMITED on January 26, 2024. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

TAKEDA PHARMACEUTICAL COMPANY LIMITED (367 trademarks)

1-1, DOSHOMACHI 4-CHOME
CHUO-KU, OSAKA , JP

Entity Type: 03

Trademark Details

Filing Date

January 26, 2024

Registration Date

Not Registered

First Use Anywhere

January 1, 2020

First Use in Commerce

January 1, 2020

Goods & Services

Medical devices used for administering pharmaceutical preparations for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting pharmaceutical preparations for use in treating or diagnosing disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders; medical devices for reconstituting and administering pharmaceutical preparations. for use in treating or diagnosing, disorders, diseases, and rare diseases in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, hematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, genetic diseases and disorders, urological diseases and disorders, kidney diseases and disorders, viral diseases and disorders

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 2, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 2, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2024 NWOS
NEW APPLICATION ENTERED
Jan 26, 2024 NWAP